Delaware high court to re­view ex­pert tes­ti­mo­ny in Zan­tac suits, in win for drug­mak­ers

Ten of the plain­tiff-cho­sen ex­perts ex­pect­ed to tes­ti­fy in lit­i­ga­tion over whether the heart­burn drug Zan­tac caused can­cer will be re­viewed by the Delaware Supreme …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA